Your browser doesn't support javascript.
loading
HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
Watera, Christine; Ssemwanga, Deogratius; Namayanja, Grace; Asio, Juliet; Lutalo, Tom; Namale, Alice; Sanyu, Grace; Ssewanyana, Isaac; Gonzalez-Salazar, Jesus Fidel; Nazziwa, Jamirah; Nanyonjo, Maria; Raizes, Elliot; Kabuga, Usher; Mwangi, Christina; Kirungi, Wilford; Musinguzi, Joshua; Mugagga, Kaggwa; Mbidde, Edward Katongole; Kaleebu, Pontiano.
Affiliation
  • Watera C; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
  • Ssemwanga D; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
  • Namayanja G; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.
  • Asio J; United States Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB, Kampala, Uganda.
  • Lutalo T; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
  • Namale A; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
  • Sanyu G; United States Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB, Kampala, Uganda.
  • Ssewanyana I; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
  • Gonzalez-Salazar JF; Central Public Health Laboratories (CPHL), Kampala, Uganda.
  • Nazziwa J; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.
  • Nanyonjo M; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.
  • Raizes E; Medical Research Council (MRC)/UVRI and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.
  • Kabuga U; United States Centers for Disease Control and Prevention Division of Global HIV and TB, Atlanta, GA, USA.
  • Mwangi C; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
  • Kirungi W; United States Centers for Disease Control and Prevention (CDC) Division of Global HIV and TB, Kampala, Uganda.
  • Musinguzi J; Ministry of Health, AIDS Control Programme, Kampala, Uganda.
  • Mugagga K; Ministry of Health, AIDS Control Programme, Kampala, Uganda.
  • Mbidde EK; World Health Organization (WHO), Kampala, Uganda.
  • Kaleebu P; Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
J Antimicrob Chemother ; 76(9): 2407-2414, 2021 08 12.
Article in En | MEDLINE | ID: mdl-33993252
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: J Antimicrob Chemother Year: 2021 Type: Article Affiliation country: Uganda
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: J Antimicrob Chemother Year: 2021 Type: Article Affiliation country: Uganda